Literature DB >> 15199133

Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/- mice.

Chantal Moratz1, J Russell Hayman, Hua Gu, John H Kehrl.   

Abstract

Normal lymphoid tissue development and function depend upon chemokine-directed cell migration. Since chemokines signal through heterotrimeric G-protein-coupled receptors, RGS proteins, which act as GTPase-activating proteins for Galpha subunits, likely fine tune the cellular responses to chemokines. Here we show that Rgs1(-/-) mice possess B cells that respond excessively and desensitize improperly to the chemokines CXCL12 and CXCL13. Many of the B-cell follicles in the spleens of Rgs1(-/-) mice have germinal centers even in the absence of immune stimulation. Furthermore, immunization of these mice leads to exaggerated germinal center formation; partial disruption of the normal architecture of the spleen and Peyer's patches; and abnormal trafficking of immunoglobulin-secreting cells. These results reveal the importance of a regulatory mechanism that limits and desensitizes chemokine receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15199133      PMCID: PMC480912          DOI: 10.1128/MCB.24.13.5767-5775.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

Review 1.  The role of chemokines in regulating cell migration during humoral immune responses.

Authors:  F Melchers; A G Rolink; C Schaniel
Journal:  Cell       Date:  1999-11-12       Impact factor: 41.582

Review 2.  Chemokines in tissue-specific and microenvironment-specific lymphocyte homing.

Authors:  J J Campbell; E C Butcher
Journal:  Curr Opin Immunol       Date:  2000-06       Impact factor: 7.486

Review 3.  Chemokines in lymphopoiesis and lymphoid organ development.

Authors:  K M Ansel; J G Cyster
Journal:  Curr Opin Immunol       Date:  2001-04       Impact factor: 7.486

Review 4.  The role of chemokines in linking innate and adaptive immunity.

Authors:  Andrew D Luster
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

5.  Lessons learned from lymphocytes: CC chemokine receptor-7 involved in lymphogenic metastasis of melanoma.

Authors:  R Förster; L Ohl; G Henning
Journal:  J Natl Cancer Inst       Date:  2001-11-07       Impact factor: 13.506

6.  Regulator of G protein signaling 1 (RGS1) markedly impairs Gi alpha signaling responses of B lymphocytes.

Authors:  C Moratz; V H Kang; K M Druey; C S Shi; A Scheschonka; P M Murphy; T Kozasa; J H Kehrl
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

7.  Evolution of the regulators of G-protein signaling multigene family in mouse and human.

Authors:  David A Sierra; Debra J Gilbert; Deborah Householder; Nick V Grishin; Kan Yu; Pallavi Ukidwe; Sheryll A Barker; Wei He; Theodore G Wensel; Glen Otero; Greg Brown; Neal G Copeland; Nancy A Jenkins; Thomas M Wilkie
Journal:  Genomics       Date:  2002-02       Impact factor: 5.736

8.  RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines.

Authors:  K Reif; J G Cyster
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

9.  A coordinated change in chemokine responsiveness guides plasma cell movements.

Authors:  D C Hargreaves; P L Hyman; T T Lu; V N Ngo; A Bidgol; G Suzuki; Y R Zou; D R Littman; J G Cyster
Journal:  J Exp Med       Date:  2001-07-02       Impact factor: 14.307

Review 10.  Chemokine receptors: multifaceted therapeutic targets.

Authors:  Amanda E I Proudfoot
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

View more
  39 in total

Review 1.  Cytokine regulation of B-cell migratory behavior favors formation of germinal centers in autoimmune disease.

Authors:  John D Mountz; John H Wang; Shutao Xie; Hui-Chen Hsu
Journal:  Discov Med       Date:  2011-01       Impact factor: 2.970

2.  The actin-bundling protein L-plastin is essential for marginal zone B cell development.

Authors:  Elizabeth M Todd; Lauren E Deady; Sharon Celeste Morley
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

Review 3.  Regulators of G-protein signaling and their Gα substrates: promises and challenges in their use as drug discovery targets.

Authors:  Adam J Kimple; Dustin E Bosch; Patrick M Giguère; David P Siderovski
Journal:  Pharmacol Rev       Date:  2011-07-07       Impact factor: 25.468

Review 4.  Therapeutic approaches for celiac disease.

Authors:  Nicholas M Plugis; Chaitan Khosla
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-05-09       Impact factor: 3.043

Review 5.  Chemoattractant receptor signaling and the control of lymphocyte migration.

Authors:  John H Kehrl
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

6.  Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes.

Authors:  Markus Feuerer; Wenyu Jiang; Phillip D Holler; Ansuman Satpathy; Christopher Campbell; Molly Bogue; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

Review 7.  Regulation of G-protein-coupled signaling pathways in allergic inflammation.

Authors:  Kirk M Druey
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

8.  Systematic comparison of gene expression between murine memory and naive B cells demonstrates that memory B cells have unique signaling capabilities.

Authors:  Mary M Tomayko; Shannon M Anderson; Catherine E Brayton; Saheli Sadanand; Natalie C Steinel; Timothy W Behrens; Mark J Shlomchik
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  Variations in Gnai2 and Rgs1 expression affect chemokine receptor signaling and the organization of secondary lymphoid organs.

Authors:  I Y Hwang; C Park; K A Harrision; N N Huang; J H Kehrl
Journal:  Genes Immun       Date:  2010-05-27       Impact factor: 2.676

10.  TLR4 signaling augments B lymphocyte migration and overcomes the restriction that limits access to germinal center dark zones.

Authors:  Il-Young Hwang; Chung Park; Kathleen Harrison; John H Kehrl
Journal:  J Exp Med       Date:  2009-11-16       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.